Clinical trials show that a single injection of nirsevimab significantly reduces severe illness from respiratory syncytial virus, which sickens millions of kids each year. Nearly all children will be infected by respiratory syncytial virus, or RSV, by the time they turn 2. Most experience common cold symptoms and recover within […]
Approved by the FDA, the vaccine will soon be available for adults 60 or older Respiratory syncytial virus, known as RSV, is a lung infection that’s highly contagious. “RSV is the poster child for what’s called paramyxoviruses, which is a family of viruses that can cause mild infections,” says pediatric […]
After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way. On Wednesday, the US Food and Drug Administration approved Arexvy, made by GSK, which is designed to be given as a single shot to […]
Vaccines for the world’s most deadly diseases, like cancer and heart disease, will likely be ready by 2030 and could save millions of lives, according to the top doctor at one the world’s leading drug companies. The announcement is yet another sign of what many are calling “the golden age” […]
Before 2020, annual respiratory syncytial virus (RSV) epidemics tended to begin in October, peak in December, and end by April. But patterns changed after the pandemic began, according to US Centers for Disease Control and Prevention data collected between 2017 and 2023. No typical winter RSV epidemic occurred during 2020-2021. […]
Summary What is already known about this topic? In the United States, the timing of seasonal respiratory syncytial virus (RSV) epidemics (October–April) was disrupted during the COVID-19 pandemic. What is added by this report? RSV circulation was historically low during 2020–21 and began earlier and continued longer during 2021–22 than […]
In March 2020, as the Covid-19 pandemic swept across the United States, the nation’s pediatric providers and pediatric units immediately pitched in to treat adults sickened by this then-mysterious and deadly disease. But now that the pediatric community is facing its own March 2020 with the confluence of Covid-19, influenza, […]
Abstract SARS-CoV-2 viral load and detection of infectious virus in the respiratory tract are the two key parameters for estimating infectiousness. As shedding of infectious virus is required for onward transmission, understanding shedding characteristics is relevant for public health interventions. Viral shedding is influenced by biological characteristics of the virus, […]
Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults. RSV is the most common cause of bronchiolitis (inflammation of the small airways in the […]
Watch for the big three red flags – cardiac (ischaemia, tachyarrhythmia, myocarditis and pericarditis), neurological (TIA and stroke) and respiratory (pulmonary embolism) in patients with long COVID, says the GP lead of one of the country’s first long COVID clinics. Dr Harsha Master, lead in COVID assessment and rehabilitation, Hertfordshire Community NHS […]
